Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
31.18
-0.68 (-2.13%)
At close: Nov 20, 2025, 4:00 PM EST
31.79
+0.61 (1.96%)
After-hours: Nov 20, 2025, 7:02 PM EST
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $3 billion as of November 20, 2025. Its market cap has decreased by -36.19% in one year.
Market Cap
3.00B
Enterprise Value
3.42B
1-Year Change
-36.19%
Ranking
Category
Stock Price
$31.18
Market Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $3.00B, an increase of 152.57%. That is a compound annual growth rate of 8.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 3.07B | -20.88% |
| Dec 31, 2024 | 3.88B | -1.06% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
| Jan 31, 2014 | 1.19B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 934.14B |
| Johnson & Johnson | 489.26B |
| AbbVie | 405.53B |
| UnitedHealth Group | 282.20B |
| AstraZeneca | 277.11B |
| Novartis AG | 239.24B |
| Merck & Co. | 235.72B |
| Abbott Laboratories | 215.57B |